Biodesix Looks to Become ‘the’ Lung Cancer Detection Co. With New Acquisition

The Boulder, CO-based company is extending its blood-based lung cancer diagnostic portfolio with the acquisition of Oncimmune’s laboratory and incidental pulmonary nodule malignancy test in the U.S.